Thomas C Neylan Selected Research

Thomas C Neylan Research Topics

Disease

85	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2022 - 01/2002
20	Wounds and Injuries (Trauma) 11/2022 - 01/2002
8	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 05/2014
8	Inflammation (Inflammations) 10/2020 - 05/2012
5	Cognitive Dysfunction 01/2022 - 08/2014
4	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 01/2005
4	Pain (Aches) 12/2021 - 03/2012
3	Alcoholism (Alcohol Abuse) 01/2022 - 08/2014
3	Mental Disorders (Mental Disorder) 10/2021 - 05/2004
3	Substance-Related Disorders (Drug Abuse) 01/2020 - 04/2015
2	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2022 - 08/2021
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2022 - 01/2019
2	Major Depressive Disorder (Major Depressive Disorders) 12/2019 - 12/2017
2	Dementia (Dementias) 01/2019 - 10/2017
2	Anxiety Disorders (Anxiety Disorder) 12/2017 - 11/2013
2	Social Phobia 12/2017 - 05/2014
2	Hypertension (High Blood Pressure) 03/2016 - 01/2005
2	Insulin Resistance 04/2015 - 11/2014
2	Coronary Disease (Coronary Heart Disease) 09/2013 - 11/2005
1	Tinnitus 01/2022
1	COVID-19 01/2022
1	Infections 01/2022
1	Apnea 01/2022
1	Sleepiness 01/2022
1	Acute Traumatic Stress Disorders (Acute Stress Disorder) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Obstructive Sleep Apnea 06/2020
1	Seizures (Absence Seizure) 06/2020
1	Drug Resistant Epilepsy 06/2020
1	Depressive Disorder (Melancholia) 03/2020
1	Corticobasal Degeneration 10/2019
1	Parasomnias (Parasomnia) 01/2019

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 06/2022 - 08/2006
16	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2022 - 09/2003
12	Biological ProductsIBA 11/2022 - 07/2006
8	C-Reactive ProteinIBA 10/2020 - 05/2012
5	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2022 - 01/2020
5	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 01/2020 - 07/2006
5	NBI 77860IBA 01/2020 - 06/2014
5	Metyrapone FDA Link 01/2018 - 09/2003
5	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018 - 09/2003
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2017
4	Fibrinogen (Factor I)FDA Link 10/2020 - 09/2013
4	Corticotropin-Releasing HormoneIBA 01/2020 - 06/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2012
4	CytokinesIBA 01/2019 - 11/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2012
4	CatecholaminesIBA 02/2015 - 11/2005
4	N-acetylaspartate (N-acetyl aspartate)IBA 08/2011 - 11/2003
3	Antipsychotic Agents (Antipsychotics)IBA 06/2022 - 04/2015
3	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2022 - 11/2021
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2021 - 10/2010
3	Trazodone (Trittico)FDA LinkGeneric 01/2021 - 01/2017
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 11/2005
3	Opioid Analgesics (Opioids)IBA 01/2016 - 03/2012
3	Dexamethasone (Maxidex)FDA LinkGeneric 06/2005 - 11/2003
2	GlucocorticoidsIBA 10/2022 - 01/2018
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 06/2022 - 01/2021
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2022 - 01/2021
2	Mirtazapine (Rexer)FDA LinkGeneric 06/2022 - 01/2021
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2022 - 01/2020
2	BenzodiazepinesIBA 01/2021 - 01/2017
2	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 03/2012
2	Prazosin (Minipress)FDA LinkGeneric 01/2021 - 01/2017
2	Zolpidem (Ambien)FDA LinkGeneric 10/2020 - 01/2017
2	CRF receptor type 1IBA 11/2018 - 12/2017
2	Glucose (Dextrose)FDA LinkGeneric 04/2015 - 11/2014
2	Antidepressive Agents (Antidepressants)IBA 03/2011 - 01/2002
2	Adrenergic Agents (Adrenergic Drugs)IBA 05/2004 - 01/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2022
1	N-Methylaspartate (NMDA)IBA 10/2022
1	Cycloserine (Seromycin)FDA Link 10/2022
1	Amyloid beta-PeptidesIBA 06/2022
1	ApolipoproteinsIBA 06/2022
1	COVID-19 VaccinesIBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	florbetapirIBA 01/2021
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	E 10 (E-10)IBA 12/2020
1	OrexinsIBA 10/2020
1	almorexantIBA 10/2020
1	Nitrous Oxide (Laughing Gas)IBA 01/2020
1	Fluoxetine (Prozac)FDA LinkGeneric 12/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Interferon Type IIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	D 53IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2016

Therapy/Procedure

18	Therapeutics 11/2022 - 04/2003
5	Drug Therapy (Chemotherapy) 10/2021 - 01/2002
2	Deep Brain Stimulation 01/2022 - 06/2020
2	Autogenic Training 01/2022 - 12/2021
2	Cognitive Training 08/2021 - 01/2021
1	Vagus Nerve Stimulation 06/2020
1	Ambulatory Care (Outpatient Care) 12/2019
1	Vocational Rehabilitation 09/2019
1	Aftercare (After-Treatment) 12/2017